Syk Inhibitor II

CAS No. 726695-51-8

Syk Inhibitor II( —— )

Catalog No. M17582 CAS No. 726695-51-8

Syk inhibitor II, a cell-permeable, ATP-competitive, pyrimidine-carboxamide compound, selectively and reversibly inhibits Syk (IC50 = 41 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 82 In Stock
5MG 60 In Stock
10MG 113 In Stock
50MG 295 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Syk Inhibitor II
  • Note
    Research use only, not for human use.
  • Brief Description
    Syk inhibitor II, a cell-permeable, ATP-competitive, pyrimidine-carboxamide compound, selectively and reversibly inhibits Syk (IC50 = 41 nM).
  • Description
    Syk inhibitor II, a cell-permeable, ATP-competitive, pyrimidine-carboxamide compound, selectively and reversibly inhibits Syk (IC50 = 41 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    Syk
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    726695-51-8
  • Formula Weight
    340.3
  • Molecular Formula
    C14H15F3N6O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (14.69 mM)
  • SMILES
    NCCNC1=NC(NC2=CC(C(F)(F)F)=CC=C2)=C(C(N)=O)C=N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hisamichi H,etal.Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure-activity relationships of pyrimidine-5-carboxamide derivatives.Bioorg Med Chem. 2005 Aug 15;13(16):4936-51.
molnova catalog
related products
  • Bleomycin sulfate

    An anticancer agent that acts by induction of DNA strand breaks; also inhibits incorporation of thymidine into DNA strands.

  • Apricitabine

    Apricitabine (SPD754) is a highly selective and orally active HIV-1 reverse transcriptase inhibitor (Ki=0.08 μM), the (-) enantiomer of 2′-deoxy-3′-oxy-4′-thiocytidine (dOTC) .

  • G150

    G150 inhibited interferon expression triggered by DSDNA with IC50 of 10.2 nM.